Product Images Topiramate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Topiramate NDC 60760-514 by St. Mary's Medical Park Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

top - Topiramate 60760 514 60

top - Topiramate 60760 514 60

This is a description of a medication named Topiramate. The medication comes in the form of tablets with a 100mg strength. The tablets are packaged in a bottle of quantity 60, and the bottle has a lot number and an expiration date. The medication is manufactured by Cadila Healthcare Ltd. in Ahmedabad, India. The medication should be stored at a controlled room temperature of 15°- 30° C (59°-86°F).*

Structured product formula for Topiramate - a9eed983 edf1 4f44 a8ec 568a52f03015 01

Structured product formula for Topiramate - a9eed983 edf1 4f44 a8ec 568a52f03015 01

Structured product formula for Topiramate - a9eed983 edf1 4f44 a8ec 568a52f03015 02

Structured product formula for Topiramate - a9eed983 edf1 4f44 a8ec 568a52f03015 02

The text describes a figure (Figure 1) that shows the cumulative rates for time to first seizure. The figure displays Kaplan-Meier estimates of cumulative rates for two different groups: one group that took topiramate 50 mg/day (N=234) and another group that took topiramate 400 mg/day (N=236). The x-axis shows time in days, and the y-axis shows the cumulative rate. The text suggests that the figure is part of a study or research on seizures and the effects of topiramate.*

Topiramate Tablets USP - a9eed983 edf1 4f44 a8ec 568a52f03015 03

Topiramate Tablets USP - a9eed983 edf1 4f44 a8ec 568a52f03015 03

The text describes the results of a study regarding migraines and the effects of topiramate and placebo over a certain period, showing a change from baseline to double-blind phase in average monthly migraine period rate with different dosages of topiramate and placebo. There are also statistical significance markers displayed.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.